Product Reports Resources Pricing Login Book a demo

10X Genomics

Biotech & Life Sciences · Pleasanton, United States · Founded 2012 · IPO 2019

Building tools for scientific discovery that reveal and address the true complexities of biology and disease

Valuation $5.54B
Revenue $614M
Power Law Unicorn$1–10B valuation tier Thoroughbred$100M+ revenue
Featured in
News Cathie Wood's ARK buys $28M in Cerebras, trims Palantir and Shopify Aug 14, 2026 News Haga Bioscience raises $2.3M in oversubscribed seed round to bridge spatial biomarker discovery and clinical translation Jun 3, 2026 News Countable Labs raises $26M Series A led by ARCH for single-molecule PCR May 28, 2026

Talent graph

10X Genomics's talent

Book a demo to see the people
Employees mapped 2,413 incl. 8 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 6 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 10 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

10 investors on 10X Genomics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 10 investors entered at this stage
Verge Genomics
Shivom
SoftBank Vision Fund
Fidelity Investments
Foresite Capital
Venrock
Wells Fargo Capital Finance
Sophia Genetics
Meritech Capital
Paladin Capital Group

10X Genomics mafia

Startups founded by 10X Genomics alumni

Former 10X Genomics employees who went on to start their own companies. Sorted by Dealroom signal score.

MoleculentEst. 2021
Olle EricssonSweden
Signal score93
PixelgenEst. 2020
Alvaro Martinez BarrioSweden
Signal score90
InfinimmuneEst. 2022
MGMichael GibbonsUnited States
Signal score77
CubaseBioEst. 2024
Xiaoyan QianSweden
Signal score75
OmniscopeEst. 2021
VVVijay VaswaniSpain
Signal score73
Ultima GenomicsEst. 2016
Mark PrattUnited States
Signal score70
PawCo FoodsEst. 2021
Mahsa VazinUnited States
Signal score69
ZafrensEst. 2021
Ravi RamenaniUnited States
Signal score64
VoxlBioEst. 2024
DGDaniel GyllborgSweden
Signal score63
AikiumEst. 2022
Eswar IUnited States
Signal score61

Book a demo to explore the full alumni network →

Global footprint

Where 10X Genomics has talent and traffic

Workforce by country
34 countries with
team presence
🇺🇸 United States74.1%
🇸🇬 Singapore5.9%
🇬🇧 United Kingdom3.1%
🇳🇱 Netherlands3%
🇩🇪 Germany2.4%
Top 5 of 34 shown
Web traffic by country
400K monthly visits
across markets
🇮🇹 Italy23.6%
🇺🇸 United States22.1%
🏳️ Korea6%
🏳️ Republic of4.9%
🇫🇷 France4.3%
Top 5 markets shown

Patent intelligence

$254M patent portfolio · 578 active families

Estimated portfolio value
$254M
4.6% of market cap · 28× smaller than top peer Janssen Vaccines ($7.1B)
578 active patent families
Where 10X Genomics innovates Molecular biologyAnalyteBiochemistryBioinformaticsBiophysics

Where 10X Genomics concentrates vs peers

Each axis is a top-10 topic across 10X Genomics and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

10X Genomics's 6 investments and acquisitions.

Every disclosed deal where 10X Genomics appeared as a backer or acquirer, 2018–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

6 deals across 10X Genomics's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        01 · Deployment strategy vs peers

        Where 10X Genomics deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        02 · Portfolio market map

        10X Genomics's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        6 of 6 deals

        Market sentiment

        What the market is saying about 10X Genomics

        An AI-synthesized read of the highest-engagement posts about 10X Genomics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See 10X Genomics on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

        Book a demo Explore company profiles